Skip to main content

Table 1 Antibodies used in this study

From: Differential responses to immune checkpoint inhibitor dictated by pre-existing differential immune profiles in squamous cell carcinomas caused by same initial oncogenic drivers

Flow Antibodies

Antibody

Fluorophore

Company

Catalog

Clone

Concentration

  CD11c

PerCP/Cy5.5

BioLegend

117327

N418

1 μg/mL

  PD-L1

BV786

BD Bioscience

741014

MIH5

1 μg/mL

  MHCII

BV711

BioLegend

107643

M5/114/15/2

0.25 μg/mL

  CD19

Brilliant Violet 605

BioLegend

115539

6D5

1 μg/mL

  Ly6C

BV421

BioLegend

128031

HK1.4

1 μg/mL

  Ly6C

FITC

BioLegend

128006

HK1.4

1 μg/mL

  Ly-6G

APC/Cy7

BioLegend

127623

1A8

1 μg/mL

  CD11b

Alexa Fluor 700

BioLegend

101222

M1/70

1 μg/mL

  CD206

PE/Cy7

BioLegend

141719

C068C2

1 μg/mL

  CD86

BV421

BioLegend

105031

GL-1

1 μg/mL

  F4/80

PE Dazzle

BioLegend

123145

BM8

1 μg/mL

  TCR beta

BV605

BioLegend

109241

H57–597

1 μg/mL

  CD4

BV421

BioLegend

100563

RM4–5

1 μg/mL

  CD8a

Alexa Fluor 700

BioLegend

100729

53–6.7

1 μg/mL

  CD45

BUV395

BD Bioscience

564279

30-F11

1 μg/mL

  TNFalpha

BV650

BD Bioscience

563943

mp6-xt22

1 μg/mL

  IFN gamma

PE

eBioscience

12–7311-41

XMG1.2

1 μg/mL

  Granzyme B

PE/Cy7

BioLegend

372213

QA16A02

1 μg/mL

Western Blotting and Histology Antibodies

Antibody

Application

Company

Catalog

Clone

Dilution

  STAT3

Western

Cell Signaling Technology

12640S

D3Z2G

1:1000

  p-STAT3

Western

Cell Signaling Technology

9145S

D3A7

1:2000

  GAPDH

Western

Cell Signaling Technology

5174S

D16H11

1:1000

  IgG-HRP

Western

Cell Signaling Technology

7074

 

1:3000

  F4/80

MSI

Cell Signaling Technology

70076

D2S9R

1:500

  Keratin 5

MSI

Abcam

ab64081

SP27

1:200

  Arginase-1

MSI

Cell Signaling Technology

93668

D4E3M

1:500